Hamed Alavi insider trades: enVVeno Medical (NVNO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Hamed reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 13, 2024 | NVNO | ↓ Sell | 8,334 | $6.22 | $52K | Direct | Mar 15, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NVNO insiders
Open-market trades in the last 12 months
About Hamed Alavi's insider trades
Hamed Alavi is Chief Technology Officer at enVVeno Medical (NVNO). Since Mar 13, 2024, Hamed has reported no open-market purchases and 1 sale worth $52K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVNO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.